The Canadian Department of National Defence has invested approximately $8.64 million in 48 projects to find Canadian solutions to the COVID-19 virus.
Six Northern Ontario businesses have been awarded over $2.1 million in funding through the NOHFC Program geared towards supporting businesses and stimulating economic growth.
To ensure a more sustainable future for Canadians and help join the global fight against the imminent climate crisis, the Government of Canada has announced an investment of $44.3M from the SDTC Tech Fund towards 11 innovative clean technology projects.
FedDev Ontario has awarded a government grant of $7.5M for Invest WindsorEssex to develop and launch Canada’s first-ever automobility accelerator. The project will support 1,350 cleantech entrepreneurs, boost business growth, and attract $40M in foreign investment.
Through the Innovative Solutions Canada (ISC) Program, the Government of Canada has invested a total of $8 million in funding to eight Canadian companies that will research and develop innovative solutions related to managing COVID-19.
Administered through a $1.5B investment to the Clean Fuels Fund, the Canadian government is providing funding support for the research and development of cleaner fuel solutions that will aim to reduce fuel emissions pollution in Canada by 2030.
The Investments in Forest Industry Transformation (IFIT) Program Capital Investments Stream is now accepting funding requests for eligible transformative and innovative projects. The deadline to apply is July 22, 2021.
The Disruptive Technology Solutions for Cell and Gene Therapy Challenge Program supports the research and development of affordable and accessible therapy solutions for Canadians living with chronic and rare diseases and conditions.
With $101.4 billion in total spending, the new Canadian Federal Budget 2021 promises a strong recovery and growth for all Canadians by overcoming COVID-19, creating a million new jobs, and advancing cleantech innovation to combat climate change.
Administered by the Government of Canada through the Strategic Innovation Fund (SIF), an investment of up to $415 million has been awarded to support Sanofi in building an influenza vaccine biomanufacturing facility in Toronto, Ontario.